2026 Micaela Morelli: Neuroscience Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Neuroscience	68	2763	2527	108	103	311	15667

Discipline name

D-Index

World Ranking

Current World Ranking

National Ranking

Current National Ranking

Publications

Citations

Neuroscience

2763

2527

108

103

311

15667

Overview

Micaela Morelli is affiliated with the University of Cagliari in Italy. Their research primarily focuses on medicine and neuroscience, with a particular emphasis on neurology and cellular and molecular neuroscience. Morelli's work spans several subfields including molecular biology, physiology, and speech and hearing.

The scientist's research topics include:

Parkinson's Disease Mechanisms and Treatments
Neurological disorders and treatments
Neuroscience and Neuropharmacology Research
Neurotransmitter Receptor Influence on Behavior
Gut microbiota and health
Adenosine and Purinergic Signaling
Dysphagia Assessment and Management

Morelli has published multiple papers related to Parkinson's disease, with notable recent works including:

Gut Microbiota and Metabolome Alterations Associated with Parkinson's Disease, 2020, mSystems
Mitochondrial Homeostasis and Signaling in Parkinson's Disease, 2020, Frontiers in Aging Neuroscience
Clinical Phenotypes of Parkinson's Disease Associate with Distinct Gut Microbiota and Metabolome Enterotypes, 2021, Biomolecules
Genetic variants of TAS2R38 bitter taste receptor associate with distinct gut microbiota traits in Parkinson's disease: A pilot study, 2020, International Journal of Biological Macromolecules
Gut microbiota and metabolome distinctive features in Parkinson disease: Focus on levodopa and levodopa-carbidopa intrajejunal gel, 2020, European Journal of Neurology

Frequent coauthors collaborating with Morelli include:

Marcello Serra
Annalisa Pinna
Giulia Costa
Nicola Simola
Maria Antonietta Casu

The scientist's work is frequently published in venues such as:

Experimental Neurology
NeuroToxicology
Neurobiology of Disease
Frontiers in Aging Neuroscience
Frontiers in Pharmacology

Best Publications

Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal ganglia

Sergi Ferré;Kjell Fuxe;Bertil B. Fredholm;Micaela Morelli

984
Citations
Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions

Gaetano Di Chiara;Micaela Morelli;Silvana Consolo

620
Citations
Targeting adenosine A2A receptors in Parkinson's disease.

Michael A. Schwarzschild;Luigi Agnati;Kjell Fuxe;Jiang-Fan Chen

611
Citations
Evidence for a GABAergic projection from the substantia nigra to the ventromedial thalamus and to the superior colliculus of the rat.

G. Di Chiara;M.L. Porceddu;M. Morelli;M.L. Mulas

586
Citations
The 6-hydroxydopamine model of Parkinson's disease.

Nicola Simola;Micaela Morelli;Anna R. Carta

561
Citations
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.

Matthieu F. Bastide;Wassilios G. Meissner;Barbara Picconi;Stefania Fasano

511
Citations
Adenosine, adenosine A2A antagonists, and Parkinson's disease

P Jenner;A Mori;R Hauser;Micaela Morelli

283
Citations
Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms.

Rosario Moratalla;Amit Suresh Khairnar;Nicola Simola;Noelia Granado

244
Citations
Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats.

Sandro Fenu;Annalisa Pinna;Ennio Ongini;Micaela Morelli

233
Citations
[3H]Ro5-4864 benzodiazepine binding in the kainate lesioned striatum and Huntington's diseased basal ganglia

Hans Schoemaker;Micaela Morelli;Pushpa Deshmukh;Henry I. Yamamura

231
Citations
Caffeine and the dopaminergic system.

O Cauli;Micaela Morelli

230
Citations
Blockade of A2a Adenosine Receptors Positively Modulates Turning Behaviour and c-Fos Expression Induced by D1 Agonists in Dopamine-denervated Rats

A. Pinna;G. Di Chiara;J. Wardas;M. Morelli

214
Citations
Catalepsy induced by SCH 23390 in rats

Micaela Morelli;Gaetano Di Chiara

209
Citations
Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression.

M Morelli;S Fenu;A Pinna;G Di Chiara

189
Citations
Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications.

Micaela Morelli;Therese Di Paolo;Jadwiga Wardas;Frederic Calon

170
Citations
Adenosine A2A Receptors and Parkinson’s Disease

Micaela Morelli;Anna R. Carta;Peter Jenner

165
Citations
Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats.

Annalisa Pinna;Sandro Fenu;Micaela Morelli

153
Citations
Adenosine A2 receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats

Micaela Morelli;Sandro Fenu;Annalisa Pinna;Gaetano Di Chiara

151
Citations
Substantia nigra as an out-put station for striatal dopaminergic responses: role of a GABA-mediated inhibition of pars reticulata neurons.

G. Di Chiara;M. L. Porceddu;M. Morelli;M. L. Mulas

147
Citations
MK-801 potentiates dopaminergic D1 but reduces D2 responses in the 6-hydroxydopamine model of Parkinson's disease.

Micaela Morelli;Gaetano Di Chiara

147
Citations
Time and dose dependence of the 'priming' of the expression of dopamine receptor supersensitivity.

Micaela Morelli;Sandro Fenu;Luciana Garau;Gaetano Di Chiara

134
Citations
A re-evaluation of the role of superior colliculus in turning behaviour

D. Di Chiara;M. Morelli;A. Imperato;M.L. Porceddu

96
Citations